Autonomix Medical, Inc.
AMIX
$2.13
-$0.2002-8.59%
| Weiss Ratings | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.51% | |||
| 30-Day Total Return | -28.53% | |||
| 60-Day Total Return | -36.42% | |||
| 90-Day Total Return | -79.58% | |||
| Year to Date Total Return | -36.80% | |||
| 1-Year Total Return | -96.18% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -97.16% | |||
| 52-Week Low % Change | 4.23% | |||
| Price | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $82.00 | |||
| 52-Week Low Price | $2.24 | |||
| 52-Week Low Price (Date) | Mar 04, 2025 | |||
| 52-Week High Price (Date) | Mar 14, 2024 | |||
| Valuation | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.74M | |||
| Enterprise Value | -4.95M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -12.78 | |||
| Earnings Per Share Growth | -10.49% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.59 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $2.13 | |||
| Enterprise Value/EBITDA (TTM) | 0.47 | |||
| Enterprise Value/EBIT | 0.46 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.85M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 713 588 6150 | |||
| Address | 21 Waterway Avenue The Woodlands, TX 77380 | |||
| Website | autonomix.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -97.67% | |||
| Return on Equity | -- | |||
| Income Statement | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -10.57M | |||
| EBIT (TTM) | -10.75M | |||
| Net Income (TTM) | -13.63M | |||
| Net Income Avl. to Common (TTM) | -13.63M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 12.88% | |||
| EPS Diluted (TTM) | -12.78 | |||
| EPS Diluted Growth (Q YOY) | 52.30% | |||
| Balance Sheet | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.82M | |||
| Cash Per Share (Q) | $6.38 | |||
| Total Current Assets (Q) | 11.93M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 9.71M | |||
| Current Ratio (Q) | 5.315 | |||
| Book Value Per Share (Q) | $3.94 | |||
| Total Assets (Q) | 11.95M | |||
| Total Current Liabilities (Q) | 2.25M | |||
| Total Debt (Q) | 1.13M | |||
| Total Liabilities (Q) | 2.25M | |||
| Total Common Equity (Q) | 9.71M | |||
| Cash Flow | AMIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -13.00K | |||
| Cash from Financing (TTM) | 18.65M | |||
| Net Change in Cash (TTM) | 10.61M | |||
| Levered Free Cash Flow (TTM) | -4.85M | |||
| Cash from Operations (TTM) | -8.04M | |||
